Epidemiology of COPD
- PMID: 20956146
- DOI: 10.1183/09059180.00003609
Epidemiology of COPD
Abstract
Chronic obstructive pulmonary disease (COPD) is responsible for early mortality, high death rates and significant cost to health systems. The projection for 2020 indicates that COPD will be the third leading cause of death worldwide (from sixth in 1990) and fifth leading cause of years lost through early mortality or handicap (disability-adjusted life years) (12th in 1990). Active smoking remains the main risk factor, but other factors are becoming better known, such as occupational factors, infections and the role of air pollution. Prevalence of COPD varies according to country, age and sex. This disease is also associated with significant comorbidities. COPD is a disorder that includes various phenotypes, the continuum of which remains under debate. The major challenge in the coming years will be to prevent onset of smoking along with early detection of the disease in the general population.
Similar articles
-
[Epidemiology of chronic obstructive pulmonary disease].Rev Prat. 2011 Jun;61(6):769-73. Rev Prat. 2011. PMID: 21826918 French.
-
[Epidemiology of the chronic obstructive pulmonary disease: environmental and occupational risk].G Ital Med Lav Ergon. 2006 Jul-Sep;28(3):270-2. G Ital Med Lav Ergon. 2006. PMID: 17144415 Review. Italian.
-
Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution.Respirology. 2006 Sep;11(5):523-32. doi: 10.1111/j.1440-1843.2006.00886.x. Respirology. 2006. PMID: 16916323 Review.
-
[Epidemiology of chronic obstructive pulmonary disease].Rev Prat. 2004 Sep 15;54(13):1408-13. Rev Prat. 2004. PMID: 15497793 Review. French.
-
[Epidemiology of chronic obstructive pulmonary disease].Ann Ist Super Sanita. 2003;39(4):467-84. Ann Ist Super Sanita. 2003. PMID: 15098569 Review. Italian.
Cited by
-
Exacerbation predictive modelling using real-world data from the myCOPD app.Heliyon. 2024 May 14;10(10):e31201. doi: 10.1016/j.heliyon.2024.e31201. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803869 Free PMC article.
-
The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.Respir Res. 2024 May 15;25(1):208. doi: 10.1186/s12931-024-02841-y. Respir Res. 2024. PMID: 38750492 Free PMC article.
-
Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Can Respir J. 2024 Mar 12;2024:6038771. doi: 10.1155/2024/6038771. eCollection 2024. Can Respir J. 2024. PMID: 38505803 Free PMC article.
-
Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2024 Mar 15;19:753-764. doi: 10.2147/COPD.S453086. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38505581 Free PMC article. Review.
-
Comparative analysis of hemoglobin, potassium, sodium, and glucose in arterial blood gas and venous blood of patients with COPD.Sci Rep. 2024 Mar 2;14(1):5194. doi: 10.1038/s41598-024-55992-9. Sci Rep. 2024. PMID: 38431760 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical